Search Results - "Crandall, David T"

A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA) by Tandon, Rajiv, Marcus, Ronald N., Stock, Elyse G., Riera, Linda C., Kostic, Dusan, Pans, Miranda, McQuade, Robert D., Nyilas, Margaretta, Iwamoto, Taro, Crandall, David T.

“…BETA was designed to evaluate the overall effectiveness of aripiprazole in patients with schizophrenia or schizoaffective disorder treated in a general…”
Get full text

Smaller Anterior Hippocampal Formation Volume in Antipsychotic-Naive Patients With First-Episode Schizophrenia by Szeszko, Philip R., Goldberg, Ethan, Gunduz-Bruce, Handan, Ashtari, Manzar, Robinson, Delbert, Malhotra, Anil K., Lencz, Todd, Bates, John, Crandall, David T., Kane, John M., Bilder, Robert M.

“…OBJECTIVE: The authors investigated volumetric alterations of the anterior hippocampal formation in patients experiencing a first episode of schizophrenia…”
Get full text

The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies by Janicak, Philip G, Glick, Ira D, Marder, Stephen R, Crandall, David T, McQuade, Robert D, Marcus, Ronald N, Eudicone, James M, Assunção-Talbott, Sheila

“…To evaluate the efficacy of aripiprazole across a range of symptoms-positive, negative, disorganized thought, depression/anxiety, and hostility-in…”
Get full text

Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52  weeks by Kane, John M, Crandall, David T, Marcus, Ronald N, Eudicone, James, Pikalov, Andrei, Carson, William H, Swyzen, Wim

“…Abstract Background The Remission in Schizophrenia Working Group (RSWG) has defined criteria for symptomatic remission based on achieving and maintaining a…”
Get full text

White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study by Pomara, Nunzio, Crandall, David T., Choi, Steven J., Johnson, Glyn, Lim, Kelvin O.

“…Diffuse white matter pallor is the most frequent neuropathological feature of HIV-1 infection and has been found to be particularly prominent in the advanced…”
Get full text

The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: A pooled analysis of data from the pivotal trials by Kane, John M, Assunção-Talbott, Sheila, Eudicone, James M, Pikalov, Andrei, Whitehead, Richard, Crandall, David T

“…Abstract Objective To examine the efficacy of aripiprazole across symptoms in patients with acute exacerbation of schizophrenia or schizoaffective disorder…”
Get full text

Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation : A post hoc analysis of 4 randomized, placebo-controlled clinical trials by MARDER, Stephen R, WEST, Britt, LAU, Gina S, PULTZ, Joseph A, PIKALOV, Andrei, MARCUS, Ronald N, GUTIERREZ-ESTEINOU, Rolando, CRANDALL, David T

“…Patients with acute schizophrenia who are agitated typically manifest worse overall symptomatology and are generally more challenging to treat than nonagitated…”
Get full text

Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine by Newcomer, John W, Meyer, Jonathan M, Baker, Ross A, Eudicone, James M, Pikalov, Andrei, Vester-Blokland, Estelle, McQuade, Robert D, Crandall, David T, Carson, William H, Marcus, Ronald N, L'Italien, Gilbert

“…Abstract Objective Non-high-density lipoprotein cholesterol (non-HDL-C) and the triglyceride to high-density lipoprotein cholesterol ratio (TG:HDL-C) are…”
Get full text

Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline by SACHS, Gary S, GAULIN, Bruce D, GUTIERREZ-ESTEINOU, Rolando, MCQUADE, Robert D, PIKALOV, Andrei, PULTZ, Joseph A, SANCHEZ, Raymond, MARCUS, Ronald N, CRANDALL, David T

“…To examine the antimanic efficacy of the relatively nonsedating antipsychotic aripiprazole in patients with bipolar I disorder and high or low baseline levels…”
Get full text

Corrigendum to “The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: A pooled analysis of data from the pivotal trials” [Schizophrenia Research 105 (2008) 208–215] by Kane, John M, Assunção-Talbott, Sheila, Eudicone, James M, Pikalov, Andrei, Whitehead, Richard, Crandall, David T

Get full text

Intramuscular aripiprazole in the control of agitation by Currier, Glenn W, Citrome, Leslie L, Zimbroff, Dan L, Oren, Dan, Manos, George, McQuade, Robert, Pikalov, 3rd, Andrei A, Crandall, David T

“…To evaluate response to intramuscular (IM) aripiprazole injections using secondary analyses from clinical trials. Data from one trial in patients with bipolar…”
Get full text

Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations by Daniel, David G, Currier, Glenn W, Zimbroff, Dan L, Allen, Michael H, Oren, Dan, Manos, George, McQuade, Robert, Pikalov, 3rd, Andrei A, Crandall, David T

“…To report efficacy and safety of transitioning patients receiving intramuscular (IM) formulations of aripiprazole or haloperidol to their respective oral…”
Get full text

Apolipoprotein E genotype and brain white matter fractional anisotropy in the elderly by Crandall, David T., Pomara, Nunzio, Choi, Steve J., Johnson, Glyn, Lim, Kelvin O.

Get full text

Reduced anterior hippocampal volumes are associated with alternating response patterns in first episode schizophrenia by Crandall, David T., Szeszko, Philip R., Bilder, Robert M., Strous, Rael, Lieberman, Jeffrey A.

Get full text